RAPT - RAPT Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
17.79
-1.89 (-9.60%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close19.68
Open19.21
Bid17.36 x 1800
Ask17.90 x 1000
Day's Range16.49 - 19.40
52 Week Range11.85 - 42.00
Volume70,199
Avg. Volume128,925
Market Cap378.569M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-58.21
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Weekly CEO Buys Highlight
    GuruFocus.com

    Weekly CEO Buys Highlight

    Details the biggest CEO buys this past week Continue reading...

  • Business Wire

    RAPT Therapeutics Announces Pricing of Initial Public Offering

    RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced the pricing of its initial public offering of 3,000,000 shares of common stock at a public offering price of $12.00 per share. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 450,000 shares of common stock at the initial public offering price, less the underwriting discount. The shares are expected to begin trading on the Nasdaq Global Market on October 31, 2019, under the ticker symbol “RAPT.” The offering is expected to close on November 4, 2019, subject to the satisfaction of customary closing conditions.

  • Benzinga

    Rapt Therapeutics IPO: What You Need To Know

    The IPO calendar this week has a single biotech issue which has in its clinical pipeline, product candidates targeting oncology and inflammatory diseases. The IPO Terms San Francisco, California-based ...

  • Benzinga

    IPO Outlook For The Week: Cannabis, Cancer Therapy, Sushi And Holographic AR

    For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . The IPO dates below are expected but not confirmed. Dynatrace Holdings LLC (DT) will issue nearly 35.6 million shares between ...